摘要 |
The invention relates to methods to identify compounds that can treat autoimmune conditions and treat specified clinical disorders such as multiple sclerosis, ulcerative colitis or arthritis. Compounds include 17alpha-ethynylandrost-5-ene-3beta,15beta,7alpha,17beta-tetrol, 4alpha-acetoxy-17alpha-ethynylandrost-5-ene-3beta,7beta,17beta-triol, 17alpha-ethynylandrost-5-ene-3beta,4beta,7alpha,17beta-tetrol, 17alpha-ethynylandrost-5-ene-3alpha,4beta,7alpha,17beta-tetrol and 17alpha-ethynylandrost-5-ene-3alpha,4beta,17beta-triol-7-one.
|